Fungal malignant otitis externa: Pitfalls, diagnosis, and treatment

Otology and Neurotology

Volumn 33, Issue 5, 2012, Pages 769-773

  Tarazi, Antoine E ^a   Al Tawfiq, Jaffar A ^a   Abdi, Rifat F ^a  

^a SAUDI ARAMCO   (Saudi Arabia)

Author keywords

Aspergillus; Malignant otitis externa; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

AGED; ARTICLE; ASPERGILLUS; CASE REPORT; EXTERNAL OTITIS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MYCOSIS; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; ASPERGILLUS; FEMALE; HUMANS; MALE; MYCOSES; OTITIS EXTERNA; PSEUDOMONAS AERUGINOSA; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 84862860639     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3182565b46     Document Type: Review

References (15)

1. Rubin Grandis J, Branstetter BF 4th, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis 2004;4:34-9.
2. Stodulski D, Kowalska B, Stankiewicz C. Otogenic skull base osteomyelitis caused by invasive fungal infection. Case report and literature review. Eur Arch Otorhinolaryngol 2006;263:1070-6.
3. Petrak R, Pottage J, Levin S. Invasive external otitis caused by Aspergillus fumigates in an immunocompetent patient. J Infect Dis 1985;151:196.
4. Parize P, Chandesris MO, Lanternier F, et al. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review. Antimicrob Agents Chemother 2009;53:1048-53.
5. Peman J, Salavert M, Canton E, et al. Voriconazole in the management of nosocomial invasive fungal infections. Ther Clin Risk Manag 2006;2:129-58.
6. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004;25:1603-10.
7. Singh A, Al-Khabori M, Hyder MJ. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation. Otolaryngol Head Neck Surg 2005;133:121-5.
8. Jacobsen LM, Antonelli PJ. Errors in the diagnosis and management of necrotizing otitis externa. Otolaryngol Head Neck Surg 2010; 143:506-9.
9. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60.
10. Denes E, Boumediene A, Durox H, et al. Voriconazole concentrations in synovial fluid and bone tissues. J Antimicrob Chemother 2007;59:818-19.
11. Yenizehirli G, Bulut Y, Güven M, Günday E. In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens. J Laryngol Otol 2009;123:978-81.
12. Mouas H, Lutsar I, Dupont B, et al. Voriconazole/Bone Invasive Aspergillosis Study Group. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis 2005; 40:1141-7.
13. Stratov I, Korman TM, Johnson PD. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis 2003;22:277-83.
14. Tang TJ, Janssen HL, van der Vlies CH, et al. Aspergillus osteomyelitis after liver transplantation: conservative or surgical treatment? Eur J Gastroenterol Hepatol 2000;12:123-6.
15. Djalilian HR, Shamloo B, Thakkar KH, Najme-Rahim M. Treatment of culture-negative skull base osteomyelitis. Otol Neurotol 2006;27:250-5.